COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ RÉGLEMENTÉ
Sterke tussentijdse resultaten en nieuwe investeringen voor TINC
Sterke tussentijdse resultaten en nieuwe investeringen voor TINC. TINC behaalt € 18,0 miljoen nettowinst en doet € 50 miljoen nieuwe investeringen in infrastructuur. Aandeelhouders mogen € 0,58 per aandeel verwachten -
COMMUNIQUÉ DE PRESSE
Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
Dupixent achieves significant improvements in disease remission and symptoms in bullous pemphigoid study. Study met primary and key secondary endpoints with beneficial steroid-sparing effect -
-
-
-
COMMUNIQUÉ DE PRESSE
CORRECTION FROM SOURCE: Final Bell Holdings International Announces Update Regarding Rights Offering
Final Bell Holdings International Ltd. settles outstanding indebtedness of up to US$875,000 through Rights Offering. No discounts provided. Details on Rights Offering available on www.sedarplus.ca -
